11th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Bristol-Myers Squibb, Genentech, Merck & Co., Inc. and Prometheus Laboratories Inc.
11th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®


Program Co-Chairs

Jeffrey S. Weber, MD, PhD
Senior Member and Director
Donald A. Adam Comprehensive Melanoma Research Center
Moffitt Cancer Center
Tampa, FL



Omid Hamid, MD
Chief, Translational Research and Immunotherapy
Director, Melanoma Therapeutics
The Angeles Clinic and Research Institute



Keynote Speaker

Sam Donaldson







Faculty

Robert H.I. Andtbacka, MD,CM, FACS FRCSC
Associate Professor, Surgical Oncology
Department of Surgery
University of Utah
Huntsman Cancer Institute
Salt Lake City, Utah

Adil I. Daud, MD
Clinical Professor of Medicine and Dermatology
Division of Hematology/Oncology
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

Kevin Kim, MD
Oncologist; Director of Clinical Research
Center for Melanoma Research and Treatment
California Pacific Medical Center
San Francisco, CA

Mario Lacouture MD
Memorial Sloan-Kettering Cancer Center
New York, NY

Jason Luke, MD, FACP
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, IL

Mario Sznol, MD
Professor of Medicine (Medical Oncology)
Yale School of Medicine
Clinical Research Program Leader, Melanoma Program
Co-Director of Yale SPORE in Skin Cancer
Yale Cancer Center
New Haven, CT

Ahmad Tarhini, MD, PhD
Associate Professor
Dept of Medicine, Hematology-Oncology
Clinical and Translational Science Institute
University of Pittsburgh School of Medicine
Pittsburgh, PA


Faculty, Staff, and Planners' Disclosures

The following individuals have no relevant financial relationships with commercial interests to disclose:
The staff of Physicians' Education Resource®, LLC: Ann C. Lichti, CHCP; Beth Cameron PhD; and Megan O'Connell.

The following individuals have relevant financial relationships with commercial interests to disclose:

Robert Andtbacka, MD -- Consultant: Amgen, Provectus;  Adil I. Daud, MD -- Grant /Research Support: Merck, Pfizer, GlaxoSmithKline, Novartis, Genentech, Roche, Bristol-Myers Squibb; Consultant: Genentech, Bristol-Myers Squibb, Amgen, Celgene, Median Technologies; Stock/ Shareholder: OncoSec; Mario Lacouture, MD -- Grant Research/Support: Berg, Bristol-Myers Squibb, Genentech; Jason Luke, MD -- Consultant: Genentech, Amgen, Bayer; Hamid Omid, MD -- Bristol-Myers Squibb, GlaxoSmithKline, Roche, Merck, Incyte, Eisai, MedImmune, Merck-Serano, Pfizer, Novartis, Immunocore; Consultant: Bristol-Myers Squibb, Roche, Genentech, Amgen, Merck; Speakers Bureau: Bristol-Myers Squibb, Genentech, GlaxoSmithKline; Mario Sznol, MD -- Consultant: Genentech-Roche, Bristol-Myers, Astra Zeneca/Medimmune, Pfizer; Novartis, Kyowa-Kirin, Amgen, Merus, Seattle Genetics, Immune Design, Prometheus, Anaeropharma, Astellas-Agensys, Immunova, Nektar, Neostem, Pierre-Fabre; Other: Advisory Board: Lion Biotechnologies and Symphogen; Shareholder: Amphivena, Adaptive Biotech; Ahmad Tarhini, MD -- Research/ Grant Research: Merck, Bristol-Myers Squibb, Novartis,  Amgen; Consultant: Merck, Bristol-Myers Squibb, Genentech; Jeffrey Weber, MD, PhD -- Grant/ Research Support: Bristol-Myers Squibb, GlaxoSmithKline; Merck, Incyte, Genentech; Consultant: Bristol-Myers Squibb, GlaxoSmithKline, Merck, Incyte, Genentech, AstraZeneca, Meddivation; Shareholder: Altor, Celldex, cCAM

 


Calendar of Events
Filter By